Open access
Jun 2026
Immuno-Metabolic Reprogramming in Metabolic Syndrome and Its Cardiovascular Complications: An Integrative Bioinformatics Study
It is suggested that coordinated immune-inflammatory and metabolic signaling networks contribute to the progression from MeS to DMCAD and may serve as potential biomarkers and therapeutic targets for inflammation-driven cardiometabolic disease.
Komal Shrivastav, Sushama Jadhav, Pratik Mahajan et al.
· International Journal of Mol... · 0 citations